Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Atropine and Polypeptides

supplement:

Polypeptides

Research Papers that Mention the Interaction

Atropine inhibited the PP response to electrical stimulation.
The Journal of clinical investigation  •  1978  |  View Paper
Increasing doses of atropine attenuated the ethnic difference in PP (P = 0.01) but not in early insulin secretory responses (P = 0.6), an effect that was not due to differences in gastric emptying rate (acetaminophen test) and/or circulating glucose.
Secretion of insulin and PP was inhibited by atropine (both P < 0.001).
Diabetes  •  2004  |  View Paper
Atropine markedly decreased trypsin output (p <0.05) and plasma concentrations of PP (p <0.05) and abolished the cycling of interdigestive pancreatic secretion and motor activity.
Pancreas  •  1993  |  View Paper
Atropine completely blocked PP release and almost abolished CCK release, whereas gastrin output was enhanced.
Digestion  •  1990  |  View Paper
Atropine 1 mg in the basal state had no effect on the plasma gastrin concentrations but led to significant decrease in plasma PP concentrations.
The plasma PP level was markedly increased by MSF, and was antagonized by atropine.
The Tohoku journal of experimental medicine  •  1984  |  View Paper
Atropine blocked the release of PP during GRP and neurotensin infusion.
Regulatory Peptides  •  1983  |  View Paper
Pretreatment by atropine tended to lower the basal plasma PP level and significantly blunted the cerulein-induced PP secretion.
The American journal of gastroenterology  •  1980  |  View Paper
Diphenhydramine and atropine both reduce the intestinal inhibitory responses to the three polypeptides without reducing the intestinal inhibitory responses to epinephrine or papaverine.
The Journal of pharmacology and experimental therapeutics  •  1963  |  View Paper
Atropine also significantly decreased PNS transmission to the islet, as reflected by PP levels similar to those observed with trimethaphan.
The Journal of clinical endocrinology and metabolism  •  2001  |  View Paper
Atropine (100 micrograms ILV) significantly reduced the postprandial PP secretion in both the cephalic and the gastrointestinal phases, whereas increased insulin and glucose levels were unaffected.
Centrally administered atropine was able to suppress the basal secretion of PP as well as the secretions stimulated by hypoglycemia and food intake.
Pretreatment with 20, 100, and 200 micrograms ILV atropine significantly decreased the PP response to insulin-induced hypoglycemia, with the integrated PP response to 58, 32, and 26% of that of controls respectively.
The Journal of endocrinology  •  1997  |  View Paper
Show More